TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2026
Back to search
Official data from USPTO
VYVAMIND NEUROSTIMULANT + FOCUS AID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
03/22/2026
Trademark type
Combined
Nice classes
5
Filing date
10/05/2022
Registration date
11/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2023
Last transaction
03/22/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2022-02-00
First use in commerce
2022-02-00
Drawing code
3
Owner type
16
Owner location
LONDON, GB
Examiner
SABAGH, LAILA TAREK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word element "vyvamind Neurostimulant + Focus Aid" represented in a stylized font. The word elements "vyvamind" is located inside a rectangle shaped box and the word element "Neurostimulant + Focus Aid" is located below the box.
Holders and representatives
Holders
SAP NUTRITION LTD
Representatives
Marek Krizka TRAMA LEGAL, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements
Publications
History of USPTO decisions and trademark events.
17 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/20/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/20/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2023
PUBO
PUBLISHED FOR OPPOSITION
08/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2023
DOCK
ASSIGNED TO EXAMINER
07/19/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
NWAP
NEW APPLICATION ENTERED
10/08/2022
Continuous trademark protection
Get notified about every new filing that threatens VYVAMIND NEUROSTIMULANT + FOCUS AID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.